Provided by Tiger Trade Technology Pte. Ltd.

Novavax

9.85
-0.3400-3.34%
Pre-market: 9.70-0.1500-1.52%08:49 EDT
Volume:4.44M
Turnover:43.82M
Market Cap:1.62B
PE:-6.49
High:10.24
Open:10.02
Low:9.73
Close:10.19
52wk High:11.97
52wk Low:6.20
Shares:164.43M
Float Shares:143.00M
Volume Ratio:0.71
T/O Rate:3.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5181
EPS(LYR):2.58
ROE:-898.20%
ROA:-6.51%
PB:-8.49
PE(LYR):3.82

Loading ...

Novavax Inc. Stock Rallies 5.4%, Outperforms Peers

Dow Jones
·
Jun 30

Novavax Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jun 27

Novavax Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jun 25

Novavax Shareholders Approve Directors, Pay and Incentive Plans

TIPRANKS
·
Jun 23

Novavax shareholders ratify Ernst & Young as 2026 auditor

Reuters
·
Jun 23

Novavax Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 23

Novavax put volume heavy and directionally bearish

TIPRANKS
·
Jun 22

Novavax Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Jun 19

Mabion Signs Annex To Extend Production Agreement With Novavax To End of 2029

Reuters
·
Jun 18

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 18

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 16

Novavax (NVAX) Stock Revalued After Pivot To Sanofi Deal And Matrix M Licensing Model

Simply Wall St.
·
Jun 13

Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA) and Novavax (NVAX)

TIPRANKS
·
Jun 12

Novavax Price Target Maintained With a $19.00/Share by BTIG

Dow Jones
·
Jun 12

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 12

Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Jun 11

Novavax Inc. Stock Sheds 9.2%, Underperforms Peers

Dow Jones
·
Jun 09

Novavax Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Jun 06

Novavax’s Combo COVID-19 and Flu Shot Trial Reaches Key Milestone for Older Adults

TIPRANKS
·
Jun 06

Novavax and Sanofi Advance Omicron JN.1 Booster With Completed Phase 3 Study

TIPRANKS
·
Jun 06